GLYPROLINES AS MODULATORS OF IMMUNOREACTIVITY WITHIN CONDITIONS OF “SOCIAL” STRESS

The most important direction in the development of modern medical science is the study of protective, compensatory and pathological reactions of the organism that occur in response to various stress factors.

The aim of the study is the subsequent development of methods for pharmacological correction of these reactions. The remedies for the correction of stress-induced immunity disorders are represented by the glyprolin group – the Selank drug and the Pro-Gly-Pro peptide compound – and are of particular interest. The aim of the experiment was to study the immunomodulating effect of glyprolines on the basis of the “social stress” model.

Materials and methods. The experiment was performed on non-linear male rats aged 6-8 months. A model of a sensor contact was used as a model of the experimental “social stress”. The animals were divided into groups (n = 10): a “control” group was represented by individuals with aggressive and submissive types of behavior, formed within the conditions of the experimental “social stress” for 20 days; and 2 experimental groups in which the animals were intraperitoneally administered Selank (100 µg/kg) and Pro-Gly-Pro (100 µg/kg) against the background of the experimental “social” stress once a day for 20 days. A functional activity of the immune system was studied on the basis of standard immunopharmacological tests: a delayed-type hypersensitivity test (DTH test), a direct agglutination test (DAT), a latex test for studying the Neutrophil phagocytic rate of peripheral blood, and the essessment of the leucogram.

Results. It has been established, that within the conditions of the “social” stress, the changes in the immune response are multidirectional. That fact confirms the theory of “the immune disbalance” caused by the action of stressors. As a result of studying the effect of glyprolines within the conditions of “the social stress”, Selank and Pro-Gly-Pro proved to be effective immunocorrectors, restoring cellular and humoral immunogenesis reactions as well as the phagocytic activity of neutrophils and leucogram indices.

Сonclusion. The carried out study expands understanding of the immunoreaction pathogenesis within the stress-induced conditions in order to further develop a pharmacological strategy for correcting the revealed disorders through the substances of the neuropeptide structure.

1. Bulgakova OS. Immunitet i razlichnye stadii stressornogo vozdejstviya [Immunity and various stages of stress effects]. Successes of modern natural science. 2011; 4: 31–35. Russian

2. Khnychenko LK, Sapronov NS. Stress i ego rol’ v razvitii patologicheskih processov [Stress and its role in the development of pathological processes]. Reviews of the clinical pharmacology and drug therapy. 2003; 2(3): 2–15. Russian

3. Deak T, Quinn М, Cidlowski JA, et al. Neuroimmune mechanisms of stress: sex differences, developmental plasticity, and implications for stress-related disease. Stress. 2015; 18(4): 367–380. DOI: 10.3109/10253890.2015.1053451

4. Titov VN. Biologicheskaya funkciya stressa, vrozhdennyj immunitet, reakciya vospaleniya i arterial’naya gipertoniya [Biological function of stress, congenital immunity, inflammation reaction and arterial hypertension]. Clinical laboratory diagnostics. 2008; 12: 3-16. Russian

5. Fedorova OV, Kraiushkina NG, Schefer EG, et al. Poststressovaya modulyaciya organov immunogeneza [Post-stress modulation of immunogenesis organs]. Bulletin of Volgograd State Medical University. 2010; 3(35): 8–12. Russian

6. Khavinson VKh, Kvetnoy IМ, Ashmarin IP. Peptidergicheskaya regulyaciya gomeostaza [Peptidergic regulation of homeostasis] Successes of modern biology. 2002; 122(2): 190–203. Russian

7. Smith EM. Neuropeptides as signal molecules in common with leukocytes and the hypothalamic-pituitary-adrenal axis. Brain, Behavior, and Immunity. 2008; 22(1): 3–14. DOI: 10.1016/j.bbi.2007.08.005

8. Ashmarin IP, Koroleva SV. Zakonomernosti vzaimodejstviya i funkcional’nyj kontinuum nejropeptidov (na puti k edinoj koncepcii): Obzor [Regularities of interaction and functional continuum of neuropeptides (on the way to a unified concept): Overview]. Bulletin of the Russian Academy of Medical Sciences. 2002; 6: 40–48. Russian

9. Lyapina LA, Myasoyedov NF, Grigor’yeva ME, et al. Sovremennaya koncepciya regulyatornoj roli peptidov gliprolinovogo ryada v korrekcii funkcii sistemy gemostaza pri razvitii saharnogo diabeta [The modern concept of the regulatory role of glyproline peptides in the correction of the function of the hemostasis system in the development of diabetes mellitus]. Proceedings of the Russian Academy of Sciences, biological series. 2013; 4: 453–462. Russian

10. Teleshova ES, Bochkarev VK, Syunyakov TS, et al. Rezul’taty kliniko-farmakologicheskogo issledovaniya peptidnogo anksiolitika selanka [The results of clinical and pharmacological studies of the peptide anxiolytic Selank]. Psychiatry. 2010; 46(4): 26–35. Russian

11. Storozhevykh TP, Tukhbatova GR, Senilova YAE, et al. Vliyanie semaksa i ego fragmenta Pro-Gly-Pro na kal’cievyj gomeostaz nejronov i ih vyzhivaemost’ v usloviyah glutamatnoj toksichnosti [Effects of semax and its Pro-Gly-Pro fragment on calcium homeostasis of neurons and their survival under conditions of glutamate toxicity]. Bulletin of experimental biology and medicine. 2007: 143(50); 538-541. DOI: 10.1007/s10517-007-0192-x

12. Kopylova G.N., Bakaeva Z.V., Badmaeva S.E., et al. Terapevticheskie effekty gliprolinov (PGP, GP i PG) v otnoshenii stressogennyh narushenij povedeniya krys [Therapeutic ef

13. fects of glyprolines (PGP, GP, and PG) in rats with stress-induced behavioral disorders]. Bulletin of experimental biology and medicine. 2007; 143(2): 124–127. DOI: 10.1007/ s10517-007-0040-z

14. Skrebitsky VG, Kasyan AP, Povarov IS, et al. Nejropeptidnyj preparat Selank: biologicheskaya aktivnost’ i fundamental’nye mekhanizmy dejstviya [Neuropeptide drug Selank: biological activity and fundamental mechanisms of action]. Nervous diseases. 2016; 4: 52–56. Russian

15. Kudryavtseva NN. Serotonergicheskij kontrol’ agressivnogo povedeniya: novye podhody – novye interpretacii (obzor) [Serotonergic control of aggressive behavior: new approaches – new interpretations (review)]. Journal of Higher Nervous Activity. I.P. Pavlova. 2015; 65(5): 546. DOI: 10.7868/S0044467715050081

16. Avgustinovich DF, Kovalenko IL, Kudryavtseva NN. A model of anxious depression: persistence of behavioral pathology. 2005: 35(9); 917–924. DOI: 10.1007/s11055-005-0146-6

17. Grippo A.J, Wu KD., Hassan I., et al. Social isolation in prairie voles induces behaviors relevant to negative affect: toward the development of a rodent model focused on co-occurring depression and anxiety. Depression and Anxiety. 2008; 25: 17–26. DOI: 10.1002/da.20375

18. Koolhaas JM, de Boer SF, Buwalda B, et al. Social stress models in rodents: Towards enhanced validity. Neurobiol Stress. 2017; Feb; 6: 104–112. DOI: 10.1016/j.ynstr.2016.09.003

19. Mironov AN, Bunyatyan ND, Vasil’ev NA, et al. Rukovodstvo po provedeniyu doklinicheskih issledovanij lekarstvennyh sredstv. CHast’ pervaya [A guide to preclinical drug research. Part One]. Moscow: Grief and K, 2012. Russian

20. Snelgrove RJ. Targeting of a common receptor shared by CXCL8 and N-Ac-PGP as a therapeutic strategy to alleviate chronic neutrophilic lung diseases. Eur. J. Pharmacol. 2011; 667: 1–5. DOI: 10.1016/j.ejphar.2011.05.073

21. Kolomin T., Shadrina M., Morozova M., et al. The temporary dynamics of inflammation-related genes expression under tuſtsin analog Selank action. Molecular Immunology. 2014; 58(1): 50–55. DOI: 10.1016/j.molimm.2013.11.002

22. Volkova A., Shadrina M., Kolomin T., et al. Selank аdministration affects the expression of some genes involved in gabaergic neurotransmission. Frontiers in Pharmacology. 2016; 7: 31.